雌激素受体与乳腺癌的自然病程。
Estrogen receptor and natural course of breast cancer.
作者信息
Singhakowinta A, Potter H G, Buroker T R, Samal B, Brooks S C, Vaitkevicius V K
出版信息
Ann Surg. 1976 Jan;183(1):84-8. doi: 10.1097/00000658-197601000-00017.
Abstract
The tumors from approximately 50% of patients with breast cancer contained estrogen receptor (ER). ER appeared more often and at higher levels in the tumors of postmenopausal women. Eleven out of 12 patients who had multiple ER assays from various metastatic sites showed no significant discrepancies in ER values. ER level appears to decrease as the duration of metastatic cancer increase. Patients with ER in the tumor more frequently have bone metastases than those without ER. Visceral metastases occurred more often with ER negative patients and appeared to have a more malignant course with significant shorter survival.
摘要
大约50%的乳腺癌患者肿瘤含有雌激素受体（ER）。ER在绝经后女性的肿瘤中出现得更频繁且水平更高。12例来自不同转移部位进行多次ER检测的患者中，有11例ER值无显著差异。随着转移性癌症病程延长，ER水平似乎会降低。肿瘤中有ER的患者比没有ER的患者更常发生骨转移。内脏转移在ER阴性患者中更常见，且似乎病程更凶险，生存期显著缩短。
相似文献
1
Estrogen receptor and natural course of breast cancer.雌激素受体与乳腺癌的自然病程。
Ann Surg. 1976 Jan;183(1):84-8. doi: 10.1097/00000658-197601000-00017.
2
Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.原发性乳腺癌中雌激素受体的病理及预后相关性评估
Ann Surg. 1982 Dec;196(6):636-41. doi: 10.1097/00000658-198212001-00003.
3
The surgical implications of estrophile protein estimations in carcinoma of the breast.雌激素亲和蛋白测定在乳腺癌中的外科手术意义
Surgery. 1976 Oct;80(4):506-12.
4
Prediction of relapse and survival in breast cancer patients by pS2 protein status.通过pS2蛋白状态预测乳腺癌患者的复发和生存情况。
Cancer Res. 1990 Jul 1;50(13):3832-7.
5
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.雌激素和孕激素对恶性细胞的直接作用促进了管腔型乳腺癌转移以及肿瘤从休眠状态的唤醒。
Breast Cancer Res. 2014 Dec 5;16(6):489. doi: 10.1186/s13058-014-0489-4.
6
Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.根据雌激素受体状态，HER2 过表达乳腺癌的复发和转移模式。
Cancer Chemother Pharmacol. 2010 Aug;66(3):507-16. doi: 10.1007/s00280-009-1190-7. Epub 2009 Dec 3.
7
Estrogen receptors and breast cancer: prognostic and therapeutic implications.雌激素受体与乳腺癌：预后及治疗意义
Surgery. 1980 Sep;88(3):386-93.
8
The prediction of hormonal dependency of mammary cancer.乳腺癌激素依赖性的预测。
Ann Surg. 1975 Sep;182(3):342-52. doi: 10.1097/00000658-197509000-00017.
9
In vitro clonogenic growth and metastatic potential of human operable breast cancer.人可手术乳腺癌的体外克隆生长及转移潜能
Cancer Res. 1989 Oct 1;49(19):5288-93.
10
Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer.雌激素受体异质性以及人乳腺癌中雌激素受体与氚标记胸腺嘧啶核苷标记指数之间的关系。
Oncology. 1982;39(4):197-200. doi: 10.1159/000225636.
引用本文的文献
1
Role of Estrogen Receptor-Positive/Negative Ratios in Regulating Breast Cancer.雌激素受体阳性/阴性比率在调控乳腺癌中的作用
Evid Based Complement Alternat Med. 2022 Sep 8;2022:7833389. doi: 10.1155/2022/7833389. eCollection 2022.
2
Metastatic progression of breast cancer: insights from 50 years of autopsies.乳腺癌转移进展：50 年尸检研究的新视角。
J Pathol. 2014 Jan;232(1):23-31. doi: 10.1002/path.4288.
3
Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.原发性乳腺癌中雌激素受体的病理及预后相关性评估
Ann Surg. 1982 Dec;196(6):636-41. doi: 10.1097/00000658-198212001-00003.
4
Variability of oestrogen and progesterone receptor status between primary breast cancer and nodal metastases: preliminary communication.原发性乳腺癌与淋巴结转移灶之间雌激素和孕激素受体状态的差异：初步报告
J R Soc Med. 1982 Sep;75(9):719-22. doi: 10.1177/014107688207500909.
5
The detection and evaluation of human tumor metastases.人类肿瘤转移的检测与评估。
Cancer Metastasis Rev. 1983;2(4):351-74. doi: 10.1007/BF00048567.
6
Patterns of metastasis and natural courses of breast carcinoma.乳腺癌的转移模式与自然病程。
Cancer Metastasis Rev. 1985;4(2):153-72. doi: 10.1007/BF00050693.
7
Metastatic pattern and response to endocrine therapy in human breast cancer.
Breast Cancer Res Treat. 1986;8(3):197-204. doi: 10.1007/BF01807332.
8
Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group.原发性人类乳腺癌的类固醇激素受体活性及首次转移模式。乳腺癌研究小组。
Breast Cancer Res Treat. 1991 Mar;18(1):27-32. doi: 10.1007/BF01975440.
9
Bilateral breast cancer: one disease or two?
Breast Cancer Res Treat. 1991 Nov;19(3):233-44. doi: 10.1007/BF01961160.
10
Therapy for cancer of the breast. Current status of steroid hormone receptors.乳腺癌的治疗。类固醇激素受体的现状。
West J Med. 1979 May;130(5):401-7.
本文引用的文献
1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Interaction of uterus cytosol receptor with estradiol. Equilibrium and kinetic studies.子宫胞质溶胶受体与雌二醇的相互作用。平衡和动力学研究。
Biochim Biophys Acta. 1971 Apr 20;237(1):167-72. doi: 10.1016/0304-4165(71)90045-6.
3
Classification of patients with disseminated cancer of the breast.乳腺癌播散患者的分类
Cancer. 1969 Nov;24(5):861-9. doi: 10.1002/1097-0142(196911)24:5<861::aid-cncr2820240502>3.0.co;2-3.
4
Estrogen-receptor interaction.雌激素-受体相互作用
Science. 1973 Oct 12;182(4108):126-34. doi: 10.1126/science.182.4108.126.
5
Improved gel-filtration method for analysis of estrogen receptor binding.用于雌激素受体结合分析的改良凝胶过滤法。
Anal Biochem. 1973 Feb;51(2):335-44. doi: 10.1016/0003-2697(73)90486-7.
Zotero 插件